Novartis Oncology launches a new mTOR Web site
The science of mTOR and its clinical implications are subjects of evolving understanding among the medical community. TargetmTOR.com will serve as a valuable resource to those who wish to learn more about the role of mTOR in cancer treatment. The site content includes a guide which explains how mTOR works in different diseases, including Renal Cell Carcinoma and Neuroendocrine Tumors. These are two types of cancer in which clinical trials are underway.
The site features an animated, three-dimensional illustration depicting how mTOR works in cell metabolism, growth, proliferation, and angiogenesis. Site visitors can access downloadable brochures, a glossary of terms, clinical trial information, and recent publications on mTOR. In addition, visitors can sign up for a regular eNewsletter.
Novartis Oncology plans to update the site on an ongoing basis, as new information and resources become available. To view this website, visit www.TargetmTOR.com.